SCR-LIP-000496 · Claim · machine-readable JSON →

Among 440 lower-extremity lymphedema patients, 52 had lipedema with secondary lymphedema (lipolymphedema), of whom 88.5% showed permanent foot/dorsum edema consistent with ISL stage II-III secondary lymphedema and 38.5% had a history of cellulitis.

This single-paper claim was consolidated into general propositions (R-CLM-19); its evidence now sits under:

Claim at a glance
Type
clinical association
Knowledge state
Emerging
Evidence certainty
low (GRADE)
Evidence
1 source(s)
Dates
2026-11-17 → 2026-11-17

Structured evidence, machine-compiled — not a verdict.

Auto-compiled by the Layer 1 surveillance loop; not yet human-reviewed. anthropic/claude-opus-4.8 · 2026-11-17

Evidence over time

2020The clinical characteristics of lower extremity lymphedema in 440 patients (2020) · consistent

Evidence (1)

Context (PECO)

Population440 patients with lower-extremity lymphedema, including 52 with lipolymphedema
Conditionlipedema
Exposurelipedema (with secondary lymphedema / lipolymphedema)
Comparatorother lymphedema etiologies (PhLE, CRLE, PLE)
OutcomeISL lymphedema staging, foot edema, cellulitis history
Scopeauto-ingested from Layer 1 surveillance

Answers these questions

Gaps & caveats

Auto-ingested single source; not yet human-reviewed.

Change log